Hiroki Ishioka is an author at Astellas Pharma (Japan) specializing in tumor biology, cancer research, and molecular oncology.
Top concepts
HealthMedicineOncologyCell BiologyPharmacologyTumor BiologyCancer BiologyCancer GeneticsCancer ResearchMolecular Oncology
Publications per year
2016–2025
3
3
Discovery of KRAS(G12D) selective degrader ASP3082
Tomohiro Yoshinari, Takeyuki Nagashima, Hiroki Ishioka et al. · Communications Chemistry · 2025 · 18 citations · Full text
Takeyuki Nagashima, Tomohiro Yoshinari, Yoshihiro Nishizono et al. · Cancer Research · 2023 · 17 citations
Dose-dependent Kras Degradation, Asp3082 Monotherapy, Abstract 5735 +17
Brauer indecomposability of Scott modules
Hiroki Ishioka, Naoko Kunugi · Journal of Algebra · 2016 · 10 citations
Rows per page
1–3 of 3